Atlas Trials

Gastric Cancer, Adenocarcinoma

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Gastric Cancer, Adenocarcinoma

RecordFirmDate
Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04) (NCT04704934)Daiichi Sankyo2021-05-21

Track Gastric Cancer, Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.